Skip to NavigationSkip to content

Pharmafile - Sales and Marketing News

Nabriva Therapeutics, a biotech based in Dublin, Ireland, has announced positive Phase 3 data for its antibiotic, lefamulin, which could result in a...
Gilead has unveiled the expansion of its Cork manufacturing site, involved in the creation of its treatments for HIV and hepatitis.
The EMA has judged that the benefits offered by Zinbryta do not outweigh its risks, following a review carried out by the agency’s Pharmacovigilance...
Hemlibra was widely expected to become the dominant therapeutic for treating haemophilia patients and its latest clinical trial results only cements...
The FDA has revealed its decision to approve AstraZeneca’s oral potassium-removing agent Lokelma (sodium zirconium cyclosilicate) for the treatment...
Greek parliament has decided against investigating allegations of bribery, involving Novartis and numerous high-level former politicians.
Novartis lands itself in hot water over questionable deal with Trump's lawyer, while UK MPs demand UK pharma be aligned with EU operations post-...
The first in a new class of migraine treatments has just received approval from the FDA; Amgen and Novartis’ Aimovig is the first CGRP inhibitor to...
Amgen has revealed that its PCSK9 inhibitor Repatha (evolocumab) has received approval from the European Commission in a new indication: to reduce...
Ipsen has revealed that it has received approval for the use of Cabometyx for first-line use in patients with advanced renal cell carcinoma.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches